Gilead Sciences Posts Earnings Beat But Lowers Outlook, After GILD Stock Hits Seven-Year Low

MICHAEL KREY
·3 min read
Gilead Sciences Posts Earnings Beat But Lowers Outlook, After GILD Stock Hits Seven-Year Low
Gilead Sciences Posts Earnings Beat But Lowers Outlook, After GILD Stock Hits Seven-Year Low

Gilead Sciences late Wednesday posted third-quarter earnings and sales that beat views, but the Covid-19 treatment maker lowered its outlook; GILD stock hit seven-year lows in regular trading.